Ankylosing Spondylitis: Affected Areas, Symptoms, and Systemic Manifestations
Ankylosing spondylitis (AS) is a chronic inflammatory arthritis primarily affecting the axial skeleton. It belongs to the spondyloarthritis (SpA) family and is strongly associated with HLA-B27 (90% of patients).
Primary Axial Involvement
- Sacroiliac (SI) joints: Earliest and most consistent site (sacroiliitis)
- Spine: Vertebral bodies (syndesmophytes → "bamboo spine"), discovertebral junctions (Romanus lesions), facet joints
- Progressive fusion: Ankylosis → loss of spinal mobility, kyphosis
Peripheral Joint Involvement (30-50%)
- Large joints: Hips (25-35%), shoulders, knees, ankles
- Asymmetric oligoarthritis typical
- Enthesitis: Inflammation at tendon/ligament insertion — Achilles, plantar fascia, costochondral junctions
Extra-Articular Manifestations
| System | Manifestation | Frequency |
|---|---|---|
| Eyes | Acute anterior uveitis (iritis) | 25-40% (recurrent, unilateral) |
| GI | Inflammatory bowel disease (Crohn's, UC) | 5-10% clinical; up to 60% subclinical |
| Skin | Psoriasis | 10-15% |
| Cardiac | Aortic regurgitation, conduction defects, cardiomyopathy | <10% |
| Pulmonary | Apical fibrosis, restrictive lung disease | Variable |
| Renal | IgA nephropathy, amyloidosis (late) | Rare |
| Neurologic | Cauda equina syndrome (late, from dural ectasia) | Rare |
Characteristic Symptom Pattern
- Inflammatory back pain: Age <45 onset, >3 months duration, improves with exercise, worse with rest, night pain (awakens 2nd half), morning stiffness >30 min
- Alternating buttock pain
- Fatigue (inflammatory cytokine-driven)
- Enthesitis pain: Heel (Achilles/plantar), chest wall
Diagnostic Criteria (ASAS)
- Imaging arm: Sacroiliitis on imaging (X-ray: modified NY criteria; MRI: active inflammation) + ≥1 SpA feature
- Clinical arm: HLA-B27+ + ≥2 SpA features (inflammatory back pain, arthritis, enthesitis, uveitis, dactylitis, psoriasis, Crohn's/UC, good NSAID response, family history)
Treatment Overview
- NSAIDs: First-line; continuous > PRN for disease modification
- Biologics: TNF inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab), IL-17 inhibitors (secukinumab, ixekizumab), JAK inhibitors (upadacitinib)
- Physical therapy: Daily mobility, posture, breathing exercises — cornerstone
- No DMARDs (methotrexate, sulfasalazine) for axial disease — only for peripheral arthritis
- Surgery: Hip replacement, spinal osteotomy (severe fixed deformity)
Monitoring
- BASDAI (disease activity), BASFI (function), BASMI (mobility)
- CRP/ESR (correlate poorly with axial activity)
- Imaging: MRI for inflammation; X-ray for structural damage (syndesmophytes)
- Ophthalmology for uveitis screening
- Cardiac/pulmonary eval if symptoms
Key message: AS is more than back pain—it's a systemic inflammatory disease. Early rheumatology referral, NSAID trial, and MRI sacroiliac joints if clinical suspicion high. Physical therapy is non-negotiable for long-term function.
Bones, Joints & Muscles - Related Articles
- Fibromyalgia Diet: Foods to Reduce Pain & Inflammation
- Accurately Determine Your Body Frame Size: A Comprehensive Guide
- The Role of Stomach Muscular Grooves in Food Digestion
- Joint Pain: Common Causes, Symptoms, and When to See a Doctor
- Bulging Disc: Prevention, Symptoms & Management Before Rupture
- Pre-Stretching Muscle Warm-up: The Benefits of Heat
- Axial Skeleton Bone Density Testing: Understanding & Diagnosis
